跳至主要内容
临床试验/ISRCTN01523262
ISRCTN01523262已完成未知

Tryptophan depletion in patients with Selective Serotonin Reuptake Inhibitor (SSRI)-remitted anxiety disorders

Raine Medical Research Foundation (Australia)0 个研究点目标入组 12 人开始时间: 2005年5月10日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

2009 results in https://pubmed.ncbi.nlm.nih.gov/19936713/ (added 12/01/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Study 1: Primary diagnosis of obsessive-compulsive disorder (OCD), currently remitted with SSRI therapy
  • Study 2: Primary diagnosis of generalised anxiety disorder (GAD), currently remitted with SSRI therapy
  • Aged 18-65
  • Able and willing to give informed consent prior to participation

排除标准

  • 1. No significant co-morbid anxiety disorder or other psychiatric disorder including alcohol or drug dependence
  • 2. No major depressive episode with past 6 months
  • 3. No significant other illness
  • 4. No significant other medication therapy
  • 5. No psychological therapy applied this episode

研究者

发起方
Raine Medical Research Foundation (Australia)

相似试验